- Fellowship - UT Southwestern Medical Center (2001-2004), Hematology Oncology
- Residency - UT Southwestern Medical Center (1996-1998), Internal Medicine
- Internship - UT Southwestern Medical Center (1995-1996), Internal Medicine
- Medical School - University of California at San Diego School of Medicine (1991-1995)
Yu-Min Shen, M.D.
- Internal Medicine - Hematology/Oncology
- Medical Treatment of Blood Disorders (Hematology)
Yu-Min Shen, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center.
Recognized as the regional expert in coagulation disorders, Dr. Shen is a nonmalignant hematologic disorders specialist whose areas of clinical expertise include bleeding and clotting disorders, hemostasis, and thrombosis.
He serves as Chair of the Pharmacy and Therapeutic Committee’s Anticoagulation Subcommittee at both UT Southwestern and Parkland Hospital, and as Associate Director of the Hematology and Oncology Fellowship Program.
A Fellow of the American College of Physicians, Dr. Shen emigrated from Taiwan as a teenager. He is American Board of Internal Medicine certified in internal medicine, hematology, and oncology.
Dr. Shen was recognized for his excellence as an educator with UT Southwestern’s 2011 Eugene P. Frenkel Outstanding Teacher of the Year Award.
He joined the UT Southwestern faculty in 2004.
Dr. Shen has delivered a number of invited lectures internationally, nationally, and regionally and published more than 20 scholarly articles, chapters, reviews, and case reports. He serves as an ad hoc reviewer for the Journal of Clinical Oncology.
He is a member of professional organizations that include the American Society of Hematology, International Society on Thrombosis and Haemostasis, and Hemophilia and Thrombosis Research Society.
Dr. Shen earned his medical degree at the University of California, San Diego School of Medicine. He completed both an internal medicine residency and a hematology/ oncology fellowship at UT Southwestern.
He also holds a B.S. degree, with honors, in biological sciences from Stanford University.
Meet Dr. Shen
Bleeding and Clotting Disorders Specialist in Dallas
Hematology is in Yu-Min Shen, M.D.’s, blood – in more ways than one.
Dr. Shen is a nonmalignant hematologic disorders specialist, a physician who focuses on evaluating and treating noncancerous blood disorders. He’s also the son of a hematologist; during his training, he found himself drawn to the same area in which his father specialized.
Although he treats patients with a broad range of conditions – from anemia to myeloproliferative neoplasms – Dr. Shen specializes in treating bleeding and blood-clotting (coagulation) disorders such as hemophilia, von Willebrand disease, thrombosis, and hemostasis (slow or stopped blood flow).
A UT Southwestern Medical Center faculty member since 2004, Dr. Shen is fellowship trained and board certified in internal medicine, hematology, and oncology.
He works closely with his colleagues in the Department of Pathology’s Transfusion Medicine service and Reference Hemostasis Laboratory to precisely diagnose and comprehensively treat patients.
He considers himself a partner to his patients, and he believes that makes him a better doctor.
“I enjoy the relationships I have with my patients, and when I see them, I try to give each one my full attention and give them the time they need,” he says.
Over the course of his career, Dr. Shen’s keen observations have caught signs missed by others, which have led to several diagnoses and treatments that changed people’s lives.
“Everything is dependent on what I see, and if I do a good job of observing the patient, there are going to be clues. When I do a thorough physical exam and really listen to what my patients say, I usually get the information I need to correctly diagnose and treat them.”
- American College of Physician (1998), Member
- American Society of Hematology (2002), Member
- International Society on Thrombosis and Haemostasis (2003), Member
- Hemophilia and Thrombosis Research Society (2009), Member
- Eugene P. Frenkel Outstanding Teacher of the Year 2011, UT Southwestern
IgA antiphospholipid antibodies are an independent risk factor for thromboses.
Shen YM, Lee R, Frenkel E, Sarode R Lupus 2008 Nov 17 11 996-1003
Lupus anticoagulant interference in activated protein C resistance testing: in vitro phenomenon or in vivo pathophysiologic effect?
Shen YM, Cimo ML, Bai Y, Frenkel E, Sarode R Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011 Nov-Dec 17 6 E190-5
Rare deletion from the fibrinogen Bß gene in a patient with a provoked venous thrombotic event.
Shen YM, Sarode R, Bhogaraju A, Brennan S Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2011 Oct 22 7 613-5
Delayed massive pulmonary thromboembolic phenomenon following envenomation by Mojave rattlesnake (Crotalus scutulatus).
Bhagat R, Sharma K, Sarode R, Shen YM Thrombosis and haemostasis 2010 Jul 104 1 186-8
Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.
Huang LJ, Shen YM, Bulut GB British journal of haematology 2010 Mar 148 6 844-52
Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISA.
Radaideh SM, Frenkel EP, Dowell JE, Sarode R, Shen YM Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012 Mar-Apr 18 2 215-7
- IgA antiphospholipid antibodies are an independent risk factor for thromboses.
- Thrombosis & Hemostasis
- Thrombophilia testing
- Heparin-induced thrombocytopenia
- Antiphospholipid antibody syndrome
- Medical Treatment of Blood Disorders (Hematology)